The dietary isoflavone biochanin-A sensitizes prostate cancer cells to TRAIL-induced apoptosis

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 3, 2013, Pages 331-342

  Szliszka, Ewelina ^a   Czuba, Zenon P ^a   Mertas, Anna ^a   Paradysz, Andrzej ^a   Krol, Wojciech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Apoptosis; Biochanin A; Chemoprevention; Isoflavone; Prostate cancer; TRAIL

Indexed keywords

BIOCHANIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROSTATE CANCER;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENISTEIN; HUMANS; ISOFLAVONES; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, FLUORESCENCE; MOLECULAR STRUCTURE; PROSTATIC NEOPLASMS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION FACTOR RELA;

EID: 84875380411     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.01.019     Document Type: Article

References (67)

1. Crawford E.D. Understanding the epidemiology, natural history, and key pathways involved in prostate cancer. Urology 2009, 73:4-10.
2. Karan D., Thrasher J.B., Lubaroff D. Prostate cancer: Genes, environment, immunity and the use of immunotherapy. Prostate Cancer Prostatic Dis 2008, 11:230-236.
3. Watanabe M., Nakayama T., Shiraishi T., et al. Comparative studies of prostate cancer in Japan vs. United States: A review. Semin Urol Oncol 2000, 5:274-283.
4. Barqawi A., Thompson I.M., Crawford E.D. Prostate cancer chemoprevention: An overview of United States trials. J Urol 2004, 171:5-9.
5. Sonn G., Aronson W., Litwin M.S. Impact of diet on prostate cancer: Review. Prostate Cancer Prostatic Dis 2005, 8:304-310.
6. Trottier G., Boström P.J., Lawrentschuk N., et al. Nutraceuticals and prostate cancer prevention: A current review. Nat Rev Urol 2010, 7:21-30.
7. Sarkar Fh, Li Y. The role of isoflavones in cancer chemoprevention. Front Biocsi 2004, 9:2714-2724.
8. Perabo F.G.E., Von Low E.C., Ellinger J., et al. Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis 2005, 11:6-12.
9. Syed D.N., Suh Y., Afag F., et al. Dietary agents for chemoprevention of prostate cancer. Cancer Lett 2008, 265:167-176.
10. Xiao C.W. Health effects of soy protein and isoflavones in humans. J Nutr 2008, 136:1244-1249.
11. Jian L. Soy, isoflavones, and prostate cancer. Mol Nutr Food Res 2009, 53:217-226.
12. Russo G.L. Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol 2007, 74:533-544.
13. Goetzl M.A., Van Veldhuizen P.J., Trasher J.B. Effects of soy phytoestrogens on the prostate. Prostate Cancer Prostatic Dis 2007, 10:216-223.
14. Colli J.L., Amling C.L. Chemoprevention of prostate cancer: What can be recommended to patients?. Curr Urol Rep 2009, 10:165-171.
15. Hwang Y.W., Kim S.Y., Jee S.H., et al. Soy food consumption and risk of prostate cancer: A meta analysis of observational studies. Nutr Cancer 2009, 61:598-606.
16. Duffield-Lillico A.J., Dalkin B.L., Reid Me., et al. Selenium supplementation, baseline plasma selenium status, and incidence of prostate cancer: An analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 2003, 91:608-612.
17. Bass R., Perry B., Langenstroer P., et al. Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells. J Urol 2009, 181:615-619.
18. Thompson I.M., Tangen C.M., Goodman P.J., et al. Chemoprevention of prostate cancer. J Urol 2009, 182:499-507.
19. Stephenson A.J., Abouassaly R., Klein E.A. Chemoprevention of prostate cancer. Urol Clin North Am 2010, 37:11-21.
20. Andriole G.L., Bostwick D.G., Brawley O.W., et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med 2010, 362:1192-1202.
21. Bektic J., Guggenberger R., Eder I.E., et al. Molecular effects of the isoflavonoid genistein in prostate cancer. Clin Prostate Cancer 2005, 4:124-129.
22. Ratan H.L., Steward W.P., Gescher A.J., et al. Resveratrol-a prostate cancer chemopreventive agent?. Semin Urol Oncol 2002, 7:223-227.
23. Tanaka M., Fujimoto K., Chihara Y., et al. Isoflavone supplements stimulated the production of serum equol and decreased serum dihydrotestosterone levels in healthy male volunteers. Prostate Cancer Prostatic Dis 2009, 12:247-252.
24. Gardner C.D., Oelrich B., Liu J.P., et al. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation. Prostate 2009, 69:719-726.
25. Delmonte P., Rader J.I. Analysis of isoflavones in foods and dietary supplements. J AOAC Int 2006, 89:1138-1146.
26. Peterson G., Barnes S. Genistein and biochanin-A inhibit the growth oh human prostate cancer cells but not epidermal growth factor receptor tyrosine auto-phosphorylation. Prostate 1993, 22:335-345.
27. Hempstock J., Kavanagh J.P., George N.J. Growth inhibition of prostate cell lines in vitro by phytooestrogens. Br J Urol 1998, 82:560-563.
28. Jarred R.A., Keikha M., Dowling C., et al. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiol Biomarkers Prev 2002, 11:1689-1696.
29. Rice L., Samedi V.G., Medrano T.A., et al. Mechanisms of the growth inhibitory effects of the flavonoid biochanin A on LNCaP cells and xenografts. Prostate 2002, 52:201-212.
30. Van Ophoven A., Ng C.P., Patel B., et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for treatment of prostate cancer: First results and review of literature. Prostate Cancer Prostatic Dis 1999, 2:227-233.
31. Almasan A., Ashkenazi A. Apo2L/TRAIL: Apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 2003, 14:337-338.
32. Duiker E.W., Mom C.H., Jong S. The clinical trail of TRAIL. Eur J Cancer 2006, 42:2233-2240.
33. Bucur O., Ray S., Bucur M.C., et al. Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy. Front Biosci 2006, 11:1549-1568.
34. Thorburn A., Behbakht K., Ford H. TRAIL receptor-targeted therapeutics: Resistance mechanisms and strategies to avoid them. Drug Resist Update 2008, 11:17-24.
35. Zhang L., Fang B. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther 2005, 12:228-237.
36. Horinaka M., Yoshida T., Shiraishi T., et al. The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand. Mol Cancer Ther 2006, 5:945-951.
37. Tanaguchi H., Yoshida T., Horinaka M., et al. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell specific pathways in cancer cells but not in normal cells. Cancer Res 2008, 68:8918-8927.
38. Siddqui I.A., Malik A., Adhami V.M., et al. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 2008, 27:2055-2063.
39. Szliszka E, Czuba ZP, Bronikowska J, et al. Ethanolic extract of propolis (EEP) augments TRAIL-induced apoptotic death in prostate cancer cells. Evid Based Complement Alternat Med. [Epub ahead of print].
40. Jung Y.H., Heo J., Lee Y.J., et al. Quercetin enhances TRAIL-mediated apoptosis in prostate cancer cells via increased protein stability of death receptor 5. Life Sci 2010, 86:351-357.
41. Szliszka E., Czuba Z.P., Mazur B., et al. Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells. Int J Mol Sci 2010, 11:1-13.
42. Szliszka E., Czuba Z.P., Mazur B., et al. Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells. Molecules 2010, 15:5336-5353.
43. Szliszka E., Czuba Z.P., Sedek L., et al. Enhanced TRAIL-mediated apoptosis in prostate cancer cells by the bioactive compounds neobavaisoflavone and psoralidin isolated from Psoralea corylifolia. Pharmacol Rep 2011, 63:139-148.
44. Khan N., Adhami V.M., Mukhtar H. Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr Relat Cancer 2009, 17:39-52.
45. Szliszka E., Bronikowska J., Majcher A., et al. Enhanced sensitivity of hormone-refractory prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated cytotoxicity by taxanes. CEJ Urol 2009, 62:29-34.
46. Szliszka E., Czuba Z.P., Jernas K., et al. Dietary flavonoids sensitize HeLa cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Int J Mol Sci 2008, 9:56-64.
47. Ping S.Y., Hour T.C., Lin S.R., et al. Taxol synergizes with antioxidants in inhibiting hormonal refractory prostate cancer cell growth. Semin Urol Oncol 2010, 28:170-179.
48. Szliszka E., Czuba Z.P., Domino M., et al. Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells. Molecules 2009, 14:738-754.
49. Bronikowska J., Szliszka E., Czuba Z.P., et al. The combination of TRAIL and isoflavones enhances apoptosis in cancer cells. Molecules 2010, 15:2000-2015.
50. Shankar S., Chen Q., Siddiqui I., et al. Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3,4',5-trihydroxystilbene): Molecular mechanisms and therapeutic potential. J Mol Signal 2007, 2:27-36.
51. Shankar S., Siddiqui I., Srivastava R.K. Molecular mechanisms of resveratrol (3,4',5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Mol Cell Biochem 2007, 304:273-285.
52. Shankar S., Chen Q., Sarva K., et al. Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer: Molecular mechanisms of apoptosis, migration, and angiogenesis. J Mol Signal 2007, 2:1-14.
53. Shankar S., Ganapathy S., Chen Q., et al. Curcumin sensitizes TRAIL-resistant xenografts: Molecular mechanisms of apoptosis, migration, and angiogenesis. Mol Cancer 2008, 7:1-13.
54. Szliszka E., Mazur B., Zydowicz G., et al. TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells. Folia Histochem Cytobiol 2009, 47:579-585.
55. Deeb D., Jiang H., Gao X., et al. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of I kappaBalfa phosphorylation. Mol Cancer Ther 2004, 3:803-812.
56. Hsu A., Bray T.M., Helferich W.G., et al. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells. Exp Biol Med 2010, 235:90-97.
57. Szliszka E., Zydowicz G., Janoszka B., et al. Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis. Int J Oncol 2011, 38:241-253.
58. Syed D.N., Khan N., Afag F., et al. Chemoprevention of prostate cancer through dietary agents: Progress and promise. Cancer Epidemiol Biomarkers Prev 2007, 16:2193-2203.
59. Khan N., Adhami V.M., Mukhtar H. Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr Relat Cancer 2010, 17:39-52.
60. Sarkar F.H., Li Y., Wang Z., et al. Novel targets for prostate cancer chemoprevention. Endocr Relat Cancer 2010, 17:R195-R212.
61. Zhang L., Altuwaijri S., Deng F., et al. NF-kappaB regulates androgen receptor expression and prostate cancer growth. Am J Pathol 2009, 175:489-499.
62. Guseva N.V., Taghiyev A.F., Sturm M.T., et al. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines. Mol Cancer Res 2004, 2:574-584.
63. Raffoul J.J., Wang Y., Kucuk O., et al. Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 2006, 6:107.
64. Li Y., Ahmed F., Ali S., et al. Inactivation of nuclear factor-kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res 2005, 65:6934-6942.
65. Venkateswaran V., Klotz L.H. Diet and prostate cancer: Mechanisms of action and implications for chemoprevention. Nat Rev Urol 2010, 7:442-453.
66. Jacquemin G, Shirley S, Micheau O. Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: A promising approach to kill resistant cancer cells? Cell Mol Life Sci 1010;67:3115-30.
67. Szliszka E., Krol W. The role of dietary polyphenols in tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis for cancer chemoprevention. Eur J Cancer Prev 2011, 20:63-69.